Skip to main content

How Compounding Pharmacies Work in Australia

Scientific Review by Dr. Mitchell Henry Wright

PhD (Microbiology), BBiotech (Hons) · Scientific Advisor

Google Scholar Profile

Last reviewed: 14 March 2026

Dr. Wright serves as Scientific Advisor to Regeniq. He reviews the evidence base underpinning clinical protocols but does not provide clinical services or prescribe medications.

Pharmaceutical Science

A compounding pharmacy prepares your medication from raw medical-grade ingredients, following your practitioner's exact prescription. It is not a brand or a retail chain. The pharmacist builds the medication to match your script: the dose, the ingredients, the delivery method, and the specific formulation, all determined by your clinical assessment. Individual prescriptions reflect individual clinical pictures. This page explains how compounding works in Australia, what quality standards govern the process, and how TGA oversight provides regulatory controls from raw ingredient to finished product.

What Compounding Pharmacies Do (and Don't Do)

A compounding pharmacy in Australia prepares medications from individual ingredients based on a practitioner's prescription. That is a fundamentally different process from standard retail dispensing.

When you fill a script at a retail pharmacy, the pharmacist dispenses a product manufactured at scale, TGA-registered, and provided in original packaging. The medication arrived ready-made.

A compounding pharmacy operates earlier in that chain. The pharmacist receives a prescription specifying a particular formulation, dose, or delivery method, then prepares it from raw medical-grade ingredients. The quality of the final product depends not only on the ingredients but on the controls applied during preparation.

How Compounding Differs from Standard Dispensing

A standard pharmacy dispenses what the manufacturer produced. A compounding pharmacy prepares what the practitioner prescribed.

In standard dispensing: a company manufactures the medication, the TGA registers it, the pharmacy stocks it, and the pharmacist dispenses it. In compounding: your practitioner prescribes a specific formulation, the compounding pharmacy sources medical-grade ingredients, the pharmacist prepares the medication under controlled conditions, quality checks confirm strength and purity, and the finished product is dispensed.

Both pathways involve registered pharmacists under regulatory oversight. The compounding model requires the pharmacy to maintain its own quality standards at the preparation stage, because it is manufacturing the medication rather than distributing a pre-made product. That additional responsibility is why facility-level controls carry significant weight in compounding.

When Compounding Is Clinically Appropriate

Not always. That needs stating directly.

Compounding exists for situations where a commercially available product does not meet the clinical need. The patient may require a dose that is not manufactured, a version without an inactive ingredient they are allergic to, a different delivery method, or a combination no registered product contains. The decision to prescribe a compounded medication belongs to the practitioner, not the patient, and is grounded in clinical assessment.

Compounding is not a shortcut around the standard supply chain. When clinically appropriate, it fills a genuine gap. When it is not, a responsible practitioner prescribes a registered product instead. Blood work results, symptom presentation, medical history, and clinical judgement drive that decision. Individual circumstances vary.

Quality Standards and TGA Oversight

Compounding pharmacies prepare medications rather than dispensing pre-made products. That raises the standard required for quality assurance. The TGA licences these pharmacies and requires them to follow Good Manufacturing Practice (GMP), the same framework used in pharmaceutical manufacturing internationally. The logic is straightforward: when a pharmacy is producing the medication, the controls governing that production process must be at least as rigorous as those applied to factory-manufactured products.

Good Manufacturing Practice (GMP)

GMP is a set of standards that ensure products are manufactured and controlled according to defined quality benchmarks. For a compounding pharmacy in Australia, this means several independent controls operating simultaneously.

Raw ingredient testing. The pharmacist tests every ingredient for identity, purity, and strength before it enters the compounding process. Nothing untested is used. This is the first filter in the quality cascade.

Clean room controls. Sterile compounding requires clean rooms with filtered air, controlled temperature and humidity, and monitored air quality. The pharmacist works in a laminar flow hood wearing sterile gowns and gloves. The entire facility is designed to prevent contamination. It is worth noting that environmental contamination is one of the most significant risks in compounding, which is why these controls receive particular regulatory scrutiny.

Batch records. Every compounded medication carries a full record documenting which ingredients were used, their lot numbers, the exact quantities, who prepared it, when it was made, and what quality checks were performed. If a problem surfaces with any batch, the pharmacy can trace it back to each decision point. This traceability serves as a convergent evidence system: multiple independent data points confirm or question the integrity of any single product.

Strength and stability testing. The pharmacist tests the finished product to confirm it contains the correct amount of active ingredient. Expiry dates are set based on stability data, not estimation.

How to Verify a Compounding Pharmacy's Credentials

You can ask. That is the most straightforward approach.

Ask your practitioner which pharmacy will dispense your prescription and whether that pharmacy holds a TGA manufacturing licence. You can also verify state pharmacy registration through the relevant state pharmacy board.

A TGA-licensed compounding pharmacy will hold a manufacturing licence number. This is not confidential information. It is a regulatory credential, and any pharmacy that holds one should confirm it readily when asked.

If you are receiving a compounded medication and the dispensing source will not disclose its licensing status, raise that with your practitioner. The quality chain from prescriber to pharmacist to patient depends on every link being verifiable. A single unverifiable step in the chain weakens the confidence you can place in the final product.

The Prescriber-Compounder Relationship

The pathway from telehealth assessment to dispensed medication involves multiple registered professionals, each carrying independent clinical responsibilities.

1. Your practitioner assesses you through a telehealth consultation, reviewing your blood work, symptoms, medical history, and current medications. 2. The practitioner determines whether a compounded medication is clinically appropriate and writes a prescription specifying the formulation, dose, and delivery method. 3. The prescription is sent to the compounding pharmacy. 4. The pharmacist reviews the prescription for clinical appropriateness, checks for interactions, and confirms the formulation is feasible. 5. The pharmacist compounds the medication under GMP conditions, with quality checks at each stage. 6. The finished medication is dispensed to you.

Different professionals. Different checks.

If something about the prescription does not align clinically, the pharmacist is required to query it. That is not a courtesy. It is a professional obligation.

This dual layer of clinical oversight functions as a convergent safety mechanism. Two AHPRA-regulated professionals, both making independent judgements about the same patient's care. When two independent assessments converge, confidence in the clinical decision increases. Remove either one and you lose a critical check.

At Regeniq, every prescription follows this pathway. The practitioner prescribes. The compounding pharmacy compounds and dispenses. Both are registered and regulated, and both are independently accountable.

Risks and Considerations

Honesty matters here. A complete picture includes what can go wrong, not only what the system is designed to prevent.

Compounded medications are subject to less product-level regulation than factory-made medicines. A registered medicine on the ARTG underwent TGA pre-market review of that specific product. A compounded medication did not. The TGA regulates the facility and its quality standards, but each individual product is not separately evaluated before reaching the patient.

This is precisely why facility-level standards carry so much weight. GMP compliance, TGA licensing, and pharmacist oversight compensate for the absence of individual product review. The controls apply to the process rather than the product.

What can go wrong without proper oversight? Contamination from inadequate sterile technique. Medications that are too weak due to poor ingredient quality. Products that are too potent, delivering a higher dose than intended. Errors that go undetected without proper testing. These are not theoretical risks. Compounding failures have caused serious patient harm in documented cases overseas. One must be careful not to treat these as isolated incidents; they represent what happens when process controls are absent or insufficient.

The safeguard is the regulatory chain: a TGA-licensed facility, GMP compliance, registered pharmacists, and a prescriber who selects their compounding partner based on demonstrated quality. Obtaining medication from an unlicensed source removes every one of those protections. That is not a regulatory opinion. It is a patient safety observation supported by the evidence of what occurs when those controls are absent.

Frequently Asked Questions

Ask your practitioner which pharmacy will dispense your prescription and whether it holds a TGA manufacturing licence. You can also check directly with the relevant state pharmacy board. A TGA-licensed compounding pharmacy will hold a manufacturing licence number. Any pharmacy that holds one should be willing to confirm it when asked. If a dispensing source is unwilling to disclose its licensing status, that warrants further inquiry with your practitioner.

Both types undergo quality controls, but at different stages of the supply chain. Commercial products are evaluated by the TGA before reaching the market. Compounded products are governed at the facility level through regulatory standards applied to the pharmacy and the professional oversight of the pharmacist. A TGA-licensed compounding pharmacy operating under GMP conditions must meet strict standards for ingredient purity, potency, and sterility. Different checkpoints, but the same objective: a product that meets defined quality standards.

Compounding is used when no commercially available product meets the clinical need. That may involve a dose not manufactured commercially, a version without an ingredient the patient is allergic to, a different delivery method, or a combination no registered product contains. The decision is clinical and belongs to the practitioner, based on your blood work, symptom presentation, and medical history. Individual clinical pictures vary.

Your practitioner will usually work with a TGA-licensed compounding pharmacy whose quality standards they have already verified. You can ask about pharmacy selection. What matters most is that the pharmacy holds TGA licensing and follows GMP standards. Your practitioner selects a compounding pharmacy in the same way they make other clinical decisions: based on quality assurance, regulatory compliance, and established trust in the facility's processes.

References

  1. [1] Pergolizzi JV, et al. "Compounding pharmacies: who is in charge?" Pain Practice, vol. 13, no. 3, 2013, pp. 253-257. [Link]
  2. [2] Murphy KD, et al. "Quality assurance standards and their use in the preparation of parenteral systemic anticancer therapy products in healthcare establishments: a scoping review." European Journal of Hospital Pharmacy, vol. 31, no. 2, 2024, pp. 88-93. [Link]
  3. [3] Hawkins J, et al. "Quality Assurance: Compounding Record Audits for Error Prevention." International Journal of Pharmaceutical Compounding, vol. 27, no. 3, 2023. [Link]
  4. [4] Bretaudeau L, et al. "Good Manufacturing Practice (GMP) Compliance for Phage Therapy Medicinal Products." Frontiers in Microbiology, vol. 11, 2020, 1161. [Link]
  5. [5] Allen LV, et al. "Quality Control: Photodocumentation in Pharmacy Compounding." International Journal of Pharmaceutical Compounding, vol. 26, no. 2, 2022. [Link]

TGA-Licensed Compounding Pharmacy Dispensing Across Australia

Regeniq is a registered Australian telehealth clinic. A licensed compounding pharmacy staffed by registered pharmacists dispenses all prescriptions where clinically appropriate, operating under TGA manufacturing standards and Good Manufacturing Practice (GMP) requirements. An AHPRA-registered practitioner issues every prescription through a practitioner-led medical consultation conducted via live video, following an evidence-based clinical assessment that includes blood work and pathology review. All prescribing follows TGA-compliant regulatory pathways where applicable. The compounding pharmacy dispensing chain ensures ingredient quality verification, sterile preparation environments, potency confirmation, and batch records traceable through the regulatory system. It is worth noting that these controls exist because the quality of a compounded medication depends on the rigour of the process that produced it. Our scientific advisor, Dr. Mitchell Henry Wright, holds a Bachelor of Biotechnology (Honours) with specific training in pharmaceutical manufacturing processes. Every step from medical consultation to compounding pharmacy dispensing follows Australian regulatory frameworks designed to protect patient safety.

Related Articles

Are Peptides Legal in Australia?

· 9 min read

Peptides and Steroids: What's the Difference?

· 7 min read

The Performance Gap: Why Your Recovery Protocol Is Failing Your Progress

· 7 min read

Want to learn more about evidence-based telehealth?

Our Clinical Approach